Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands

Gregorowitsch, M.L.; Bongard, H. J. G. D. van den; Couwenberg, Alice M.; Young‐Afat, Danny A.; Haaring, Cees; Dalen, Thijs van; Schoenmaeckers, Ernst J. P.; Agterof, Mariette J; Baas, Inge O.; Sier, M.; Ernst, Miranda F.; Hummel, Ragna van; Verkooijen, Helena M.

doi:10.1016/j.breast.2019.08.004

Cited by 13 publications

(18 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Social support and characteristics of autonomy were assessed in some of the studies, indicating that these current job resources are associated with higher work ability, in line with results in the healthy population (Gould et al 2000) and also in populations experiencing chronic health problems (Leijten et al 2014). No data were available on the possible buffering effects of social support and autonomy on the relationship between late effects of cancer treatments and work ability.…”

Section: Discussionmentioning

confidence: 83%

“…Also, a recent European multi-country study (Torp et al 2018), reported that differences in work ability could be observed between salaried and self-employed but that the direction and magnitude of these differences differed across countries. The variation between different kinds of self-employment should probably be considered too, as self-employment occurs in very different professional areas, and among the healthy population agricultural entrepreneurs, for instance, have a lower work ability than other occupational groups (Gould et al 2000). The conclusion from this review is that the non-salaried workers among cancer survivors are reported to have a lower work ability than salaried workers.…”

Section: Limitationsmentioning

confidence: 83%

“…It is important to be aware of the very different profiles with regard to gender and age of these types of cancer. Among healthy populations age is generally associated with work ability, younger workers usually estimating their work ability at a higher level (Gould et al 2000;Berg van de et al 2010;Bender et al 2015). Also, variation among participants in the disease status may cause a lack of comparability, as there are differences between studies with regard to including participants with recurrence, or distant metastasis, while awareness of disease progression or the possibility of the cancer not being curable, might influence perceived work ability.…”

Section: Limitationsmentioning

confidence: 99%

See 2 more Smart Citations

The associations between late effects of cancer treatment, work ability and job resources: a systematic review

Boelhouwer

Vermeer

Vuuren

2020

Int Arch Occup Environ Health

View full text Add to dashboard Cite

Objective The aim of this review is to evaluate associations between possible late effects of cancer treatment (i.e. physical complaints, fatigue, or cognitive complaints) and work ability among workers beyond 2 years after cancer diagnosis who returned to work. The role of job resources (social support, autonomy, leadership style, coaching, and organizational culture) is also evaluated. Methods The search for studies was conducted in PsycINFO, Medline, Business Source Premier, ABI/Inform, CINAHL, Cochrane Library and Web of Science. A quality assessment was used to clarify the quality across studies. Results The searches included 2303 records. Finally, 36 studies were included. Work ability seemed to decline shortly after cancer treatment and recover in the first 2 years after diagnosis, although it might still be lower than among healthy workers. No data were available on the course of work ability beyond the first 2 years. Late physical complaints, fatigue and cognitive complaints were negatively related with work ability across all relevant studies. Furthermore, social support and autonomy were associated with higher work ability, but no data were available on a possible buffering effect of these job resources on the relationship between late effects and work ability. As far as reported, most research was carried out among salaried workers. Conclusion It is unknown if late effects of cancer treatment diminish work ability beyond two years after being diagnosed with cancer. Therefore, more longitudinal research into the associations between possible late effects of cancer treatment and work ability needs to be carried out. Moreover, research is needed on the buffering effect of job resources, both for salaried and self-employed workers.

show abstract

Section: Discussionmentioning

confidence: 83%

Section: Limitationsmentioning

confidence: 83%

Section: Limitationsmentioning

confidence: 99%

See 1 more Smart Citation

The associations between late effects of cancer treatment, work ability and job resources: a systematic review

Boelhouwer

Vermeer

Vuuren

2020

Int Arch Occup Environ Health

View full text Add to dashboard Cite

show abstract

“…53 The WAI was developed in Finland and is available in 24 languages, including English and Dutch. 54 The validity and reliability of the WAI has been assessed in correlation analyses and used in many international research studies.…”

Section: Work Ability Indexmentioning

confidence: 99%

Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study

et al. 2020

View full text Add to dashboard Cite

IntroductionChemotherapy is the mainstay of treatment for patients with advanced soft tissue sarcomas (STS). Treatment intent is usually palliative, aiming to improve symptoms, stabilise or reduce tumour burden and extend life. Clinical trials have traditionally used radiological response, time to progression and survival as measures of treatment efficacy. Health-related quality of life (HRQoL) is at least equally important or more important than survival for many patients with advanced cancer. Systematically collecting HRQoL data during chemotherapy can provide greater insight into treatment efficacy from the patient perspective.The primary aims of this study are to evaluate HRQoL in patients with advanced STS treated with chemotherapy over time, explore the decision-making process and patient reflection post-treatment.Methods and analysisThis is an observational, international cohort study for 132 patients aged ≥18 years with advanced STS treated at eight centres (three in the UK, five in the Netherlands). Patients will be recruited prior to starting first-line or third-line chemotherapy and invited to complete questionnaires using the Patient-Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship registry (PROFILES); an established international registry for collection of cancer patient-reported outcomes. Online (or paper) questionnaires will be completed at baseline, each cycle of chemotherapy and 2–3 monthly during follow-up. The questionnaire package includes the Decisional Conflict Scale, Control Preferences Scale, Quality–Quantity Questionnaire, treatment expectations, European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30), EORTC financial toxicity items, Work Ability Index, Functional Assessment of Cancer Therapy-General (FACT-G) items and Decisional Regret Scale. Clinical data will be extracted from patient records and linked with questionnaire responses. The primary outcome measure is the change in global HRQoL from baseline to after cycle 4 of first-line chemotherapy (based on published data showing that patients with advanced STS complete a median number of four cycles of first-line chemotherapy).Ethics and disseminationHeath Research Authority and Research Ethics Committee (REC 17/NI/0197). Results from the Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (HOLISTIC) study will be published in peer-reviewed journals and disseminated at local, national and international conferences. We will also present our findings at any appropriate patient meetings and involve patients in study-related publications.Trial registration numberNCT03621332.

show abstract

“… 32 In addition, the patient’s work ability was significantly decreased during the treatment period, and the employment rate also decreased, which may be related to the cognitive, memory, and attention-related disorders caused by the comprehensive treatment. 33 , 34 But an individual’s positive attitude towards pursuing life goals, combined with the support of families and all walks of life, can improve the quality of life of patients and even increase their survival rate. 25 , 35 Good health education can help women stay away from the breast cancer problems originally, such as weight control, reducing alcohol consumption and increasing breastfeeding, etc.…”

Section: Discussionmentioning

confidence: 99%

Effects of Breast-Conserving Surgery Combined with Immediate Autologous Fat Grafting on Oncologic Safety, Satisfaction and Psychology in Patients with Breast Cancer: A Retrospective Cohort Study

Gong

Zhou

Niu

et al. 2022

CMAR

View full text Add to dashboard Cite

Purpose Autologous fat grafting (AFG) is a technique that can improve the appearance of breasts in surgical patients. There are currently few studies on breast-conserving surgery (BCS) combined with immediate AFG, although we believe that it could achieve satisfactory effects. Therefore, the purpose of this study is to observe the effects of BCS combined with immediate AFG on oncologic safety, satisfaction and psychology of breast cancer patients. Patients and Methods We retrospectively collected the data of 85 breast cancer patients from February 2018 to October 2018. After screening, 40 patients in AFG group (AG, BCS combined with immediate AFG) and 40 patients in control group (CG, BCS alone) were finally included in the study. The primary outcomes were the survival, tumor recurrence and metastasis, and BREAST-Q score of patients. The secondary outcomes were short and long-term complications, degree of depression and anxiety of patients. Results A total of 80 patients were included in the analysis. There was no significant difference in the clinicopathological data between the two groups ( P >0.05). The average follow-up time of the two groups was 40.58±2.630 and 40.28±2.679 months. In the analysis of oncologic safety, no patients died in AG and 1 patient died in CG. In addition, there was no significant difference between the two groups in terms of the overall recurrence rate and the distribution of recurrence types ( P >0.05). As for satisfaction, the BREAST-Q score of AG was significantly higher than that of CG (57.85±4.833 vs 51.93±5.045, P <0.001). In the secondary outcomes, there was no short-term complication specified in the study; in the long-term complications, the incidence of calcification in AG was not significantly higher than that in CG ( P =0.065). In the analysis of depression and anxiety, there was no significant difference between the two groups ( P >0.05). Conclusion BCS combined with immediate AFG can significantly improve patients’ satisfaction without increasing the risk of death and tumor recurrence. However, it does not seem to play a role in improving the conditions of depression and anxiety.

show abstract

Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands

Cited by 13 publications

References 24 publications

The associations between late effects of cancer treatment, work ability and job resources: a systematic review

The associations between late effects of cancer treatment, work ability and job resources: a systematic review

Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study

Effects of Breast-Conserving Surgery Combined with Immediate Autologous Fat Grafting on Oncologic Safety, Satisfaction and Psychology in Patients with Breast Cancer: A Retrospective Cohort Study

Contact Info

Product

Resources

About